Jack Griffis

Jack Griffis serves as Chief Technology Officer at Kessel Medical since November 2021 and is a Scientific Advisor at BioCircuit Technologies since November 2019. Additionally, Jack holds a position on the Board of Directors for EarliTec Diagnostics Inc., representing Children's Healthcare of Atlanta until March 2024. Previous experience includes senior roles at MedShape, Inc., where Jack was Senior Vice President of Advanced Technologies and Vice President of R&D before the company's acquisition by DJO®. Other roles span positions such as Director of Product Development at Refocus Group, Inc., Program Manager at Facet Technologies LLC, Manager of Catheter R&D at Novoste Corporation, and Program Manager for Angioplasty at C.R. Bard's Peripheral Technologies division. Jack earned a Master of Science in Mechanical Engineering with a focus on Biomechanics and a Bachelor's degree in Aerospace and Mechanical Engineering from the Georgia Institute of Technology.